文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症小鼠骨髓细胞移植通过细胞间接触调节全身炎症反应

Bone Marrow Cells Transplant in Septic Mice Modulates Systemic Inflammatory Response via Cell-Cell Contact.
PubMed 文献 · Shock · 2019-01-01
一句话结论小鼠实验中,脓毒症造模后1小时单次静脉注射骨髓来源单核细胞可提高内毒素血症模型生存率、降低TNF-α并升高IL-10,体外机制依赖细胞直接接触。

研究采用盲肠结扎穿孔(CLP)或内毒素血症两种实验性脓毒症小鼠模型,在造模后1小时静脉注射经Ficoll梯度分离的骨髓来源单核细胞(BMDMCs),注射后2小时检测血浆、肺、心、肠细胞因子及脾、淋巴结、胸腺淋巴细胞死亡。结果显示,内毒素血症模型早期单次静脉注射BMDMCs可改善生存率,BMDMCs在肺、肝、脾持续存在至24小时,单核细胞坏死与凋亡减少,血浆TNF-α降低、IL-10升高,并呈现组织特异性细胞因子谱。体外共培养实验显示IL-6、IL-10和一氧化氮产生依赖BMDMCs与巨噬细胞直接接触,TNF-α产生受PGE2负向调节。作者认为BMDMCs可保护动物免于内毒素血症和脓毒症,减轻全身炎症并特异性调节组织炎症。

要点

  • 内毒素血症小鼠造模后1小时单次静脉注射BMDMCs可改善生存率,注射后2小时检测炎症指标。
  • BMDMCs注射后24小时仍存在于肺、肝、脾,并减少单核细胞坏死与凋亡。
  • BMDMCs降低血浆TNF-α、升高IL-10,并产生组织特异性细胞因子谱。
  • 体外实验显示IL-6、IL-10和一氧化氮产生依赖BMDMCs与巨噬细胞直接接触,TNF-α受PGE2负向调节。

适用人群与场景

  • 成年雄性Balb/c小鼠,采用盲肠结扎穿孔(CLP)或内毒素血症模型诱导实验性脓毒症。

处置流程与药物剂量

  • BMDMCs经Ficoll梯度分离,于造模后1小时单次静脉注射。
  • 注射后2小时检测血浆、肺、心、肠细胞因子浓度,脾、淋巴结、胸腺用于淋巴细胞分离与细胞死亡评估。

研究设计与关键结果

  • 内毒素血症小鼠早期单次静脉注射BMDMCs可改善生存率。
  • BMDMCs在肺、肝、脾持续存在至注射后24小时。
  • BMDMCs减少单核细胞坏死与凋亡,降低血浆TNF-α、升高IL-10,并呈现组织特异性细胞因子谱。
  • 体外共培养显示IL-6、IL-10和一氧化氮产生依赖BMDMCs与巨噬细胞直接接触,TNF-α产生受PGE2负向调节。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠CLP与内毒素血症模型)及体外细胞共培养实验。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为BMDMCs可保护动物免于内毒素血症和脓毒症,减轻全身炎症并特异性调节组织炎症,产生重新平衡炎症反应所需的免疫调节。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis is a dynamic disease, displaying an inflammatory profile that varies over time and for each organ. Controlling the inflammatory response based in targeting a single molecule has been proved useless. We hypothesized that treatment with bone marrow-derived mononuclear cells (BMDMCs) may be more efficient to modulate the systemic inflammatory response to infection. Adult male Balb/c mice were subjected to cecal ligation and puncture (CLP) or endotoxemia model of experimental sepsis. BMDMCs were separated under Ficoll gradient and injected intravenously 1 h after the procedures. Cytokines concentration was quantified in plasma, lungs, heart, and gut. Spleens, lymph nodes, and thymus were used for lymphocytes isolation and cell death assessment. All measurements were performed 2 h after BMDMCs injection. RAW264.7 macrophages and BMDMCs were cocultivated in vitro to investigate the mechanisms involved. Our data showed that an early single intravenous injection of BMDMCs in animals submitted to the murine model of endotoxemia led to the improvement of survival rate; BMDMCs persistency in lung, liver, and spleen after 24 h; decreased necrosis and apoptosis of mononuclear cells; lower TNF-α, but increased IL-10 concentration in plasma; and tissue-specific cytokine profile. In vitro experiments demonstrated that IL-6, IL-10, and nitric oxide production depends on direct contact of BMDMCs to macrophages and that TNF-α production is negatively regulated by PGE2. BMDMCs are efficient in protecting animals from endotoxemia and sepsis, reducing systemic inflammation as well as specifically modulating tissue inflammation, producing the necessary immune regulation to re-equilibrate the inflammatory response.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lorigados CB, Ariga SKK, de Lima TM, et al. Bone Marrow Cells Transplant in Septic Mice Modulates Systemic Inflammatory Response via Cell-Cell Contact. Shock. 2019. PMID: 29621118. doi:10.1097/SHK.0000000000001151

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。